U.S Markets open at 3:30pm (GMT+1)
Market Closing Performance for Tuesday,
December 12th, 2023.
==================
On Tuesday, Dec. 12th, the Dow rose +0.48%, the S&P 500 gained +0.46% and the Nasdaq-100 climbed +0.82%, with all three benchmarks marking their fourth straight day of gains.
Strong
gains were seen from mega-cap tech names such as Nvidia (+2.2%), AMD (+2.4%)
and Meta Platforms (+2.8%).
Key
Takeaways:
- Drivers of
the S&P 500: Eight of
the 11 S&P sectors finished higher, with technology, financials, and
materials leading the way. Incyte Corp. (INCY) surged to +8.75%,
its highest level since 2017 after promising results from its
Graft-Versus-Host Disease (GVHD) therapy study. The company also announced
plans to submit its biologics license application to the FDA by year-end.
- Inflation
Data: Investors reacted positively to
November's inflation data, which came in line with expectations, showing a
0.1% month increase and a 3.1% annual rise.
- FOMC Meeting: Today, Dec. 13th, the Federal Reserve
is expected to hold interest rates steady. Investors will be keen to hear
Fed Chair Jerome Powell's remarks regarding future rate cuts.
U.S
Markets Major Indices & Other Assets
Index |
Last Close |
1-Day Change |
S&P 500 |
4,643.69 |
+0.46% |
Dow Jones |
36,577.95 |
+0.48% |
Nasdaq-100 |
16,354.25 |
+0.82% |
U.S. 10-Year Treasury Yield* |
4.212% |
-0.40% |
Brent (Oil)* |
$72.79 |
-5.04% |
Bitcoin* |
$40,847.63 |
-2.15% |
*Bitcoin
is a continuously traded asset without a defined closing time. US10YR and Brent
also have different trading hours. The price displayed here represents their
values as of 8:00 am (GMT+1) on Wednesday, Dec. 13th.
Top Gainers
Company |
Ticker |
Last Close |
1-Day Change |
C4
Therapeutics Inc. |
CCCC |
$2.34 |
+98.31% |
System1
Inc. |
SST |
$2.21 |
+20.11% |
ImmunityBio
Inc. |
IBRX |
$3.72 |
+16.98% |
S&P-500's Top Gainers
Company |
Ticker |
Last Close |
1-Day Change |
Incyte Corp. |
INCY |
$61.86 |
+8.45% |
Linde Plc. |
LIN |
$426.72 |
+4.53% |
Alaska Air Group
Inc. |
ALK |
$37.31 |
+4.36% |
0 Comments